Surgical enucleation for renal cell carcinoma.
The results of an enucleative operation in 33 patients with renal carcinoma present bilaterally or in a solitary kidney are reviewed. All of the excised tumors were low grade and the majority of the patients had pathological stage I renal carcinoma. Postoperative followup ranged from 9 to 156 months (mean 45 months). The 3-year actuarial survival rate was 90 per cent. Tumor recurred locally in 2 patients (6 per cent). We conclude that enucleation is a safe technique that can yield excellent tumor control in selected patients with renal carcinoma.
D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009367:Neoplasm Staging; D009392:Nephrectomy; D011183:Postoperative Complications / Q000453:epidemiology; D011859:Radiography; D013997:Time Factors; D006623:von Hippel-Lindau Disease / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery